UK markets closed

Swiftmerge Acquisition Corp. (IVCP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
10.830.00 (0.00%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close10.83
Open10.83
Bid0.00 x 0
Ask0.00 x 0
Day's range10.83 - 10.83
52-week range10.00 - 12.20
Volume328
Avg. volume17,016
Market cap74.076M
Beta (5Y monthly)0.01
PE ratio (TTM)49.23
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.

    NEW YORK & VERO BEACH, Fla., August 11, 2023--HDL Therapeutics, Inc. ("HDL Therapeutics"), a privately held commercial stage biotech company with an FDA-approved cardiovascular therapy the Plasma Delipidation System (PDS-2™ System) for reducing coronary atheroma in patients with homozygous familial hypercholesterolemia (HoFH), has signed a definitive merger agreement with Swiftmerge Acquisition Corp. (NASDAQ: IVCP) ("Swiftmerge"), a special purpose acquisition company with a disruptive consumer